Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

BACKGROUND AND PURPOSE HIV enters the CNS early in the course of infection and produces neuropsychiatric impairment throughout the course of illness, which preferentially affects the subcortical white matter. The development of a neuroimaging marker of HIV may allow for the earliest detection of cognitive impairment. The purpose of this study was to determine whether MR diffusion tensor imaging can detect white matter abnormalities in patients who have tested positive for HIV. METHODS Ten patients with HIV (eight men and two women; mean age, 42 years) underwent MR imaging of the brain with MR diffusion tensor imaging, which included routine fluid-attenuated inversion recovery and fast spin-echo T2-weighted imaging. Diffusion constants and anisotropy indices were calculated from diffusion tensor maps. Peripheral viral load, Centers for Disease Control staging, and cluster of differentiation 4 levels were determined. RESULTS All patients had normal results of MR imaging of the brain, except for mild atrophy. Four of 10 patients had undetectable viral loads. These patients were receiving highly active antiretroviral therapy. The diffusion constant and anisotropy were normal. Four of 10 patients had viral loads between 10,000 and 200,000. Diffusion anisotropy in the splenium and genu was significantly decreased (P < .02). The diffusion constant of the subcortical white matter was elevated in the frontal and parietooccipital lobes (11%). Two of 10 patients had viral loads >400,000. Anisotropy of the splenium was half normal (P < .0004) and of the genu was decreased 25% (P < .002). The average diffusion constant was diffusely elevated in the subcortical white matter. CONCLUSION Calculating the diffusion constant and anisotropy in the subcortical white matter and corpus callosum in patients with HIV detected abnormalities despite normal-appearing white matter on MR images and nonfocal neurologic examinations. Patients with the highest diffusion constant elevations and largest anisotropy decreases had the most advanced HIV disease. Patients with the lowest viral load levels, who had normal anisotropy and diffusion constants, were receiving highly active antiretroviral therapy.

[1]  J. Kurhanewicz,et al.  Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. , 1990, AJNR. American journal of neuroradiology.

[2]  D. Dickson,et al.  Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. , 1991, Human pathology.

[3]  C. Stern,et al.  Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[4]  Michael J. Taylor,et al.  The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.

[5]  P. Portegies.  HIV-1, the brain, and combination therapy , 1995, The Lancet.

[6]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[7]  P. Basser,et al.  Diffusion tensor MR imaging of the human brain. , 1996, Radiology.

[8]  D. Simpson,et al.  Neurologic manifestations of HIV infection. , 1996, The Medical clinics of North America.

[9]  F. Clavel,et al.  Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. , 1997, AIDS.

[10]  S. Staprans,et al.  Measuring the “viral load” in cerebrospinal fluid in human immunodeficiency virus infection: Window into brain infection? , 1997, Annals of neurology.

[11]  A. Sönnerborg,et al.  Indinavir in cerebrospinal fluid of HIV-1-infected patients , 1997, The Lancet.

[12]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[13]  R N Bryan,et al.  Absolute quantitation of diffusion constants in human stroke. , 1997, Stroke.

[14]  B. Brew,et al.  Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. , 1997, The Journal of infectious diseases.

[15]  I. Grant,et al.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome , 1997, Annals of neurology.

[16]  G. Norkrans,et al.  HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy. , 1997, AIDS.

[17]  J. R. Fiore,et al.  Neurological disorders during HIV‐1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype , 1998, AIDS.

[18]  G. Norkrans,et al.  HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. , 1998, AIDS.

[19]  C. Filippi,et al.  Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. , 1998, Radiology.

[20]  D. Rottenberg,et al.  Neuroimaging of the AIDS dementia complex. , 1998, AIDS.

[21]  J. Rabkin,et al.  Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function , 1998, AIDS.

[22]  M. I. Smith,et al.  A study of rotationally invariant and symmetric indices of diffusion anisotropy. , 1999, Magnetic resonance imaging.

[23]  L. Chang,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[24]  P. V. van Zijl,et al.  Orientation‐independent diffusion imaging without tensor diagonalization: Anisotropy definitions based on physical attributes of the diffusion ellipsoid , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  J. Rabkin,et al.  The relationship between employment and neuropsychological impairment in HIV infection , 1999, Journal of the International Neuropsychological Society.

[26]  D. F. Moore,et al.  Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. , 1999, AJNR. American journal of neuroradiology.

[27]  A. Snyder,et al.  Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. , 1999, Radiology.

[28]  M E Bastin,et al.  Selecting an appropriate anisotropy index for displaying diffusion tensor imaging data with improved contrast and sensitivity , 2000, Magnetic resonance in medicine.